Il punto su
Il ruolo del microbiota intestinale nella modulazione immunitaria
The role of the intestinal microbiota in immune modulation
Davide Leardini, Edoardo Muratore, Daniele Zama, Arcangelo Prete, Andrea Pession, Riccardo Masetti
Unità di Oncologia e Ematologia Pediatrica “Lalla Seràgnoli”, Università di Bologna
Giugno 2020 | DOI: 10.53126/MEBXXIIIG130
Abstract
The intestinal microbiota plays a crucial role in numerous physiological and pathological processes of the developmental age. The development of new investigation methods, such as next generation sequencing, has allowed a more precise characterization of the intestinal microbiota. This allowed us to deepen the complex relationship between the microbial flora and our organism. One of the many functions that emerged is the ability to modulate the host's immune system. The transplantation of hematopoietic stem cells represents a privileged setting for studying this interaction since, after the procedure, we witness the immune reconstruction starting from the donor precursors. The gut microbiota influences the development of major infectious and immune-mediated complications of transplantation and has a significant impact on patient survival. These evidences underline the possible therapeutic implications of the modulation of the intestinal microbiota. An in-depth study of the relationship between the immune system and microbiotic flora could allow us to better understand the role of the latter in other infectious or immune-mediated diseases.
Riassunto
Il microbiota intestinale ha un ruolo cruciale in numerosi processi fisiologici e patologici dell’età evolutiva. Lo sviluppo di nuovi metodi di indagine, come il next generation sequencing, ha permesso una più precisa caratterizzazione del microbiota intestinale. Questo ha permesso di approfondire la complessa relazione tra la flora microbica e il nostro organismo. Una delle numerose funzioni emerse è la capacità di modulare il sistema immunitario dell’ospite. Il trapianto di cellule staminali emopoietiche rappresenta un ambito privilegiato per studiare questa interazione in quanto, dopo la procedura, si assiste alla ricostruzione immunitaria a partire dai precursori del donatore. Il microbiota intestinale influenza lo sviluppo delle principali complicanze infettive e immuno-mediate del trapianto e ha un impatto significativo sulla sopravvivenza del paziente. Queste evidenze sottolineano le possibili implicazioni terapeutiche della modulazione del microbiota intestinale. L’approfondimento della relazione tra il sistema immunitario e la flora microbiotica potrebbe permettere di comprendere meglio il ruolo di quest’ultima in altre malattie infettive o immuno-mediate.
Contenuto riservato
Per leggere l'articolo è necessario effettuare il login.
Per l'acquisto del singolo articolo scrivi a
abbonamenti@medicoebambino.com
(la mail si prepara da sola con gli estremi dell'articolo);
se accedi, la richiesta parte con un click.
Classificazione MeSH
Bibliografia
- Sender R, Fuchs S, Ron M. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016;14(8):e1002533. doi: 10.1371/journal.pbio.1002533.
- Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The Human Microbiome Project. Nature 2007;449(7164):804-10. doi: 10.1038/nature06244.
- Qin J, Li R, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-67. doi: 10.1038/nature08821.
- Finegold SM. State of the art. Microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe 2011;17(6):367-8. doi: 10.1016/j.anaerobe.2011.03.007.
- Candela M, Rampelli S, Turroni S, et al. Unbalance of intestinal microbiota in atopic children. BMC Microbiol 2012;12. doi: 10.1186/1471-2180-12-95.
- Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012;482(7384):179-85. doi: 10.1038/nature10809.
- Weingarden AR, Vaughn BP. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes 2017;8(3):238-52. doi: 10.1080/19490976.2017.1290757.
- Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med 2016;375(24):2369-79. doi: 10.1056/NEJMra1600266.
- Methé BA, Nelson KE, Pop M, et al.; Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012;486(7402):215-21. doi: 10.1038/nature11209.
- Li J, Wang J, Jia H, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014;32(8):834-41. doi: 10.1038/nbt.2942.
- Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013;504(7480):451-5. doi: 10.1038/nature12726.
- Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell 2018;33(4):570-80. doi: 10.1016/j.ccell.2018.03.015.
- Taur Y, Jenq RR, Perales MA, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014;124(7):1174-82. doi: 10.1182/blood-2014-02-554725.
- Jenq RR, Ubeda C, Taur Y, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012;209(5):903-11. doi: 10.1084/jem.20112408.
- Zama D, Biagi E, Masetti R, et al. Gut microbiota and hematopoietic stem cell transplantation: where do we stand? Bone Marrow Transplant 2017;52(1):7-14. doi: 10.1038/bmt.2016.173.
- Taur Y, Xavier JB, Lipuma L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55(7):905-14. doi: 10.1093/cid/cis580.
- Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012;489(7415):231-41. doi: 10.1038/nature11551.
- Brown RL, Clarke TB. The regulation of host defences to infection by the microbiota. Immunology 2017;150(1):1-6. doi: 10.1111/imm.12634.
- Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer 2018;18(5):283-95. doi: 10.1038/nrc.2018.10.
- Koyama M, Mukhopadhyay P, Schuster IS, et al. MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota. Immunity 2019:1-14. doi: 10.1016/j.immuni.2019.08.011.
- Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354(17):1813-26.
- Ferrara JLM, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009;373(9674):1550-61. doi: 10.1016/S0140-6736(09)60237-3.
- Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Blood 2016;128(20):2395-402. doi: 10.1182/blood-2016-06-716738.
- Holler E, Butzhammer P, Schmid K, et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant 2014;20(5):640-5. doi: 10.1016/j.bbmt.2014.01.030.
- Eriguchi Y, Takashima S, Oka H, et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood 2012;120(1):223-31. doi: 10.1182/blood-2011-12-401166.
- Levine JE, Huber E, Hammer STG, et al. Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality. Blood 2013;122(8):1505-9. doi: 10.1182/blood-2013-02-485813.
- Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016;165(6):1332-45. doi: 10.1016/j.cell.2016.05.041.
- Mathewson ND, Jenq R, Mathew A V, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 2016;17(5):505-13. doi: 10.1038/ni.3400.
- Jenq RR, Taur Y, Devlin SM, et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant 2015;21(8):1373-83. doi: 10.1016/j.bbmt.2015.04.016.
- Biagi E, Zama D, Nastasi C, et al. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant 2015;50(7):992-8. doi: 10.1038/bmt.2015.16.
- Biagi E, Zama D, Rampelli S, et al. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders. BMC Med Genomics 2019;12(1):1-11. doi: 10.1186/s12920-019-0494-7.
- Peled JU, Devlin SM, Staffas A, et al. Intestinal microbiota and relapse after hematopoietic-cell transplantation. J Clin Oncol 2017;35(15):1650-9. doi: 10.1200/JCO.2016.70.3348.
- Evans JC, Hirani DSP, Needle DJJ. Nutritional and post-transplantation outcomes of enteral versus parenteral nutrition in pediatric hematopoietic stem cell transplantation: a systematic review of randomized and non-randomized studies. Biol Blood Marrow Transplant 2019;25(8):e252-9. doi: 10.1016/j.bbmt.2019.02.023.
- D’Amico F, Biagi E, Rampelli S, et al. Enteral nutrition in pediatric patients undergoing hematopoietic SCT promotes the recovery of gut microbiome homeostasis. Nutrients 2019;11(12):2958. doi: 10.3390/nu11122958.
- Zama D, Muratore E, Biagi E, et al. Enteral nutrition protects children undergoing allogeneic hematopoietic stem cell transplantation from blood stream infections. Nutr J 2020;19(1):29. doi: 10.1186/s12937-020-00537-9.
- DeFilipp Z, Peled JU, Li S, et al. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv 2018;2(7):745-53. doi: 10.1182/bloodadvances.2018017731.
- Taur Y, Coyte K, Schluter J, et al. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med 2018;10(460):eaap9489. doi: 10.1126/scitranslmed.aap9489.
- Malard F, Mohty M. Gut microbiota alteration during allogeneic haematopoietic cell transplantation: what can we do? Br J Haematol 2020;188(3):351-3. doi: 10.1111/bjh.16204.
- Kakihana K, Fujioka Y, Suda W, et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood 2016;128(16):2083-8. doi: 10.1182/blood-2016-05-717652.